|
10:45 Recital of Verses of the Holy Quran National Anthem of the Islamic Republic of Iran
|
|||
|
10:50 Welcome Speech by Congress Scientific Secretory
Madadi S. (Iran) |
|||
|
11:00 Welcome Speech by executive Secretary of perfusion-IRANSECT
Ghanbari A. (Iran) |
|||
|
11:05 A report of scientific program of congress
Sheikhi B. (Iran) |
|||
|
11:10 Perfusion and perfusionist
Yousefnia MA. (Iran) |
|||
|
11:20 Delnido Versus modified ringer lactate- based Delnido cardioplegia impacts on clinical outcomes in patients undergoing CABGs: Pilot Study
Kachoueian N. (Iran) |
|||
|
11:35 The Evaluation of the correlation of sodium fluctuations with clinical outcomes in children undergoing CPB
Heidarinia S. (Iran) |
|||
|
11:50 Serum Ionized Calcium Levels Hemodynamic Status and Blood Transfusions in Pediatric Heart Surgery Patients
Azizi N. (Iran) |
|||
|
12:05 Q & A
|
|
13:30 Use of SvO2 venous oxygen saturation factor instead of hemoglobin level to decide on blood transfusion to patients during CPB
Hemati M. (Iran) |
|||
|
13:45 Patient Blood Management
Al-Lawati A. (Oman) |
|||
|
14:15 Cardio-micro/plegia method with modified MB solution and Effect on Blood Transfusion
Bagheri M. (Iran) |
|||
|
14:30 Patient centric and family centric, a new approach for patient blood management
Boroujerdi Alavi A. (Iran) |
|||
|
14:50 Q & A
|
|
15:15 Aortic Arch surgery, Surgical considerations and role of hemadsorption
Zeraatiannejad Davani S. (Iran) |
|||
|
15:35 Anesthesia management of ascending aorta dissection (Type A)
Askarian S. (Iran) |
|||
|
15:55 Perfusion Considerations in Aortic Arch Surgery
Sheikhi B. (Iran) |
|||
|
16:10 Connect data management system and GDP strategy
Desuki Y. (Lebanon) |
|||
|
16:25 Q & A / Discussion
|
|
17:00 Teamworking in cardiac surgery Room
Shirvani Y. (Iran) |
|||
|
17:20 Professional ethics and law, things should to know
Ghanbari A. (Iran) |
|||
|
17:40 Legal professional challenges
Heibati M. (Iran) |
|||
|
18:00 Expressing opinions, experiences and group discussion
|
|
11:45 Meet The experts
Strategies for improving patient care based on collaborative
decision-making
|
|
13:30 Meet The Experts
Principle of Palliative care in Heart Failures
|
|
15:15 Meet The Experts New Approaches in ACS (Diagnosis, Treatment and Nursing Care)
|
|
17:00 Meet The Experts Conceptual errors in homodynamic monitoring
|
|
10:45 Echocardiography in LV hypertrophy
Moshkani M. (Iran) |
|||
|
11:05 Cardiac Imaging in LV hypertrophy
Rabiee P. (Iran) |
|||
|
11:25 Highlights of HCM guideline
Ghaemi M. (Iran) |
|||
|
11:45 Athletic heart versus Hypertrophic CMP
Akiash N. (Iran) |
|||
|
12:05 Q & A
|
|
12:15 The Magic of Resilia Technology
Kalantar Motamedi MH. (Iran) |
|||
|
12:30 Mitral valve repair solutions
Sharifi M. (Iran) |
|||
|
12:45 Tricuspid valve repair, The state of the Art
Mirmohammad Sadeghi A. (Iran) |
|||
|
13:00 Open Discussion
|
|
13:30 Management of aortic aneurysm
Jahangiri M. (Iran) |
|||
|
13:50 Case Presenter
Jadbabaei N. (Iran) |
|
15:15 Mini Cardiac Surgery; Where do we stand
Amirghofran AA. (Iran) |
|||
|
15:30 Innovations in valve surgery; from ports to wire approach
Baghaei M. (UK) |
|||
|
15:45 Mini AVR (RAT VS Ministernotomy )
Babazadeh K. (Iran) |
|||
|
16:00 Mini CABG (TCRAT)
Ghavidel AA. (Iran) |
|||
|
16:15 Redo Mini Mitral Surgery; State of the Art A-Z
Sardarinia P. (Netherlands) |
|||
|
16:30 Discussion
|
|
17:00 Atrial functional MR
Jafari Fesharaki M. (Iran) |
|||
|
17:20 Assessment of secondary MR (new insights)
Sahebjam M. (Iran) |
|||
|
17:40 Assessment of TR and RV interaction
Moaref A. (Iran) |
|||
|
18:00 Case Presentation
Moradi B. (Iran) Eftekhari MR. (Iran) |
|
18:30 Iranian Society of Echocardiography Annual General Assembly
|
|
10:45 Welcome Speech by Director of the Cardiac Section of Iranian Physiotherapy Association & the Executive Secretary of Physiotherapy
Zafarnejad M. (Iran) |
|||
|
10:55 Welcome Speech by The Scientific Secretary of Physiotherapy
Saba M. (Iran) |
|||
|
11:05 Welcome Speech by The Executive Secretary of Congress
Hoseini S. (Iran) |
|||
|
11:15 Wellcome Speech by Dean of the Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, and the Secretary of the physiotherapy board
Ebrahimi E. (Iran) |
|||
|
11:25 Welcome Speech by President of the Iranian Physiotherapy Association
Moazenzadeh A. (Iran) |
|||
|
11:35 Investigating the impact of coronavirus disease on cardiovascular system
Zafarnejad M. (Iran) |
|||
|
11:55 Stress management in critical situations
Banaderakhshan H. (Iran) |
|
12:15 CRRT in Heart Failure
PD in Heart Failure
Alborzi N. (Iran) |
|
13:30 ECG for Physiotherapists (Basic)
Banaderakhshan H. (Iran) |
|||
|
14:00 ECG for Physiotherapists (Advanced)
Bakhshi M. (Iran) |
|||
|
14:30 Arterial blood gas: an indicator of physical endurance post-cardiac surgery?
Nejat R. (Iran) |
|
15:15 Diabetes mellitus pathophysiology
Vasaghi Gharamaleki B. (Iran) |
|||
|
15:45 The effect of weight-bearing exercise for better balance protocol on static, dynamic and functional balance in people with diabetic neuropathy
Ghanavati T. (Iran) |
|||
|
16:05 Review of guidelines for cardiac rehabilitation exercise programs
Shah Ali Sh. (Iran) |
|||
|
16:25 Safety and efficacy of pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID study): A prospective, randomized, single-blind, controlled trial
Javaherian M. (Iran) |
|
17:00 Physiotherapy approach in pulmonary arterial hypertension
Khosravian Arab T. (Iran) |
|||
|
17:20 COVID-19 and cardiovascular diseases
Hajibashi A. (Iran) |
|||
|
17:40 Does the coronary artery disease affect reaction time and anticipatory skill, a cross sectional study
Dabbaghipour N. (Iran) |
|||
|
18:00 Q & A
|
|
10:45 Anesthesia management for cardiovascular procedures in hybrid room
Zirak N. (Iran) |
|||
|
11:00 Implantable cardiac pulse generator: pacemakers and ICDs
Mahoori AR. (Iran) |
|||
|
11:15 Anesthesia management for non-cardiac surgery in congenital heart
disease
Yousefi M. (Iran) |
|||
|
11:30 Anesthesia management in TAVI
Azizi R. (Iran) |
|||
|
11:45 Anesthesia management in EPS
Chaibakhsh Y. (Iran) |
|||
|
12:00 Anesthesia management in non-cardiac surgery in Ischemic heart
disease
Habibi M. (Iran) |
|
12:15 All a cardiologist should know about cardiac CT
|
|
13:30 - New advances in AF ablation
- How to manage post AF ablation arrhythmia
- Case presentation
|
|
15:15 Comprehensive in-hospital monitoring in acute heart failure
Ziaie N. (Iran) |
|||
|
15:35 Inotropes: risks and benefits
Jalali S. (Iran) |
|||
|
15:55 Advances in optimization of volume management
Khabazian M. (Iran) |
|||
|
16:15 Vasodilator therapy from guideline to practice
Mohammadi S. (Iran) |
|||
|
16:35 Q & A
|
|
17:00 Reperfusion injury following pulmonary endarterectomy
Ghanbari M. (Iran) |
|||
|
17:15 Anesthetic management of women with heart failure during
pregnancy
Mesbah Kiaei M. (Iran) |
|||
|
17:30 Renal replacement therapy in patients on ECMO
Hoseinzadeh M. (Iran) |
|||
|
17:45 Acute pulmonary emboli following cholecystectomy
Shahabbasi A. (Iran) |
|||
|
18:00 Unanticipated difficult airway due to oropharyngeal stenosis in
pieere-rubin syndrome
Dayani AR. (Iran) |
|||
|
18:15 Tracheostomy tube cuff herniation
Ghadimi M. (Iran) |
|
11:45 Meet The experts
New Approach in Post cardiac Surgery Nursing care
|
|
12:15 Cardiac Mass Case 1
Shekarchizadeh M. (Iran) |
|||
|
12:35 Cardiac Mass Case 2
Rezaei -Kalantari K. (Iran) |
|||
|
12:55 Cardiac Mass Case 3
Enamzadeh E. (Iran) |
|||
|
13:10 Cardiac Mass Case 4
Shoormij R. (Iran) |
|
13:30 RNA world: the story of noncoding RNAs and their application in
cardiovascular diseases
Malakootian M. (Iran) |
|||
|
13:45 The importance of non-coding RNAs in clinics
Mowla SJ. (Iran) |
|||
|
14:00 Non coding RNAs and Cardiac fibrosis
Soltani B. (Iran) |
|||
|
14:15 Role of genetic testing in Hypercoagulable state
Sadeghipour P. (Iran) |
|||
|
14:30 The interplay between DNA and RNA variants in premature CAD
susceptibility; focusing in ANRIL lncRNA
Taheri E. (Iran) |
|||
|
14:45 Upregulation of miR-182-5p and miR-9-5p and downregulation of
Talin-1 in coronary artery disease as novel biomarkers
Gholipour A. (Iran) |
|
15:15 The clinical application of Cardiovascular Physiology in Health and
Disease
Sarraf M. (USA) |
|||
|
15:45 Q & A
|
|||
|
16:00 Cardiovascular Medicine Curriculum in Mayo Clinic
|
|
17:00 Interesting Congenital Cardiac Surgery Procedures
Jalali AH. (Iran) |
|
10:45 DTGA; What is Crucial for pre-operative patient?
Gorji M. (Iran) |
|||
|
10:55 How do you manage the older infants with D-TGA, IVS
Mirza-Aghayan MR. (Iran) |
|||
|
11:05 Surgical options for coronary anomalies in D-TGA
Gholampour M. (Iran) |
|||
|
11:15 Management of Complex TGA
Baghaei R. (Iran) |
|||
|
11:25 How do you manage PPS Post operation?
(Case Based Presentation)
Jafari F. (Iran) |
|||
|
11:35 Management of progressive AI in neo-Aorta and Ischemic events
(Case Based Presentation)
Tolouei Tabar Y. (Iran) |
|||
|
11:45 Q & A
|
|
13:30 Multiple ASDs Closure, Device or Surgery?
Zeinaloo A. (Iran) |
|||
|
13:45 ASD Closure in Adult Patients with PH?
Khajali Z. (Iran) |
|||
|
14:00 New in ASD (Sinus Venous type) closure
Experience in Pediatric Patients
Mortezaeian H. (Iran) |
|||
|
14:15 Percutaneous ASD sinus venous Type closure
Experience in Adult Patients
Firouzi A. (Iran) |
|||
|
14:30 Echo Guided ASD closure. New Iranian Experience
Sayadpour K. (Iran) |
|||
|
14:45 How should you managed the Complications after ASD Closure?
Ghaemi HR. (Iran) |
|
15:15 New aspects in Tachy-Arrhythmia (Panel)
Dalili M. (Iran) Khorgami MR. (Iran) Rahimpour F. (Iran) |
|||
|
15:45 New aspects in Brady arrhythmia (Panel)
Dalili M. (Iran) Khorgami MR. (Iran) Rahimpour F. (Iran) |
|||
|
16:15 Syncope and Sudden Cardiac Death, Cardiogenetics
Mahdieh N. (Iran) Saber S. (Iran) Kalaeinia S. (Iran) |
|
17:00 Post-transplant heart failure
Mirtajaddini M. (Iran) |
|||
|
17:15 Acute heart failure in pediatric
Naghshzan A. (Iran) |
|||
|
17:30 Right Heart failure in pediatric PH
Abbaszadeh R. (Iran) |
|||
|
17:45 Echocardiographic Evaluation in RCM &HCM
Mahdizadegan N. (Iran) |
|||
|
18:00 Neglected Etiology of Pulmonary HTN
Rezaie M. (Iran) |
|||
|
18:15 Electrophysiologic devices in pediatric heart failure
Dalili M. (Iran) |
|
10:45 Idiopathic Ventricular Arrhythmias
Seyyedhoseini M. (Iran) |
|||
|
11:05 Ischemic CMP
Eftekharzadeh M. (Iran) |
|||
|
11:25 Non Ischemic CMP
Tavousi A. (Iran) |
|||
|
11:50 VT in Pediatric Population
Dalili M. (Iran) |
|||
|
12:10 Q & A
|
|
12:15 Clinical Benefits for Contrast Saving of Dynamic Coronary Roadmap
Turkoglu Gulsah (Turkey) |
|
13:30 Cardio oncology
Jamshidi Z. (Iran) |
|||
|
13:45 Nuclear Medicine in Amyloidosis
Hedayati R. (Iran) |
|||
|
14:00 Nuclear cardiology in infection and inflammation
Maghsoudi M. (Iran) |
|||
|
14:30 Nuclear Medicine in Sarcoidosis
Ghorbani M. (Iran) |
|||
|
14:45 Panel discussion : General Nuclear cardiology
Yaghoubi N. (Iran) Malek H. (Iran) |
|
15:15 Cardiovascular involvement in adults with childhood radiation T2d
Fadavi P. (Iran) |
|||
|
15:35 Methods of reducing cardiotoxicity caused by radiation
Babaei M. (Iran) |
|||
|
15:55 Coronary artery disease in radiotherapy
Yaghoobi Jooybari A. (Iran) |
|||
|
16:15 Cardiac Implantable Electronic Devices and Radiotherapy
Sayad M. (Iran) |
|||
|
16:35 Q & A
|
|
17:00 Definition and Optimal medical treatment for advanced heart failure
Rafiei H. (Iran) |
|||
|
17:20 Clinical outcome and issues of implantable left ventricular assist
device (LVAD) treatment
Ashraf H. (Iran) |
|||
|
17:40 Heart transplantation - Still the best option? If so, for whom?
Chenaghlou M. (Iran) |
|||
|
18:00 Communications with patients and family in advanced heart failure
and end of life
Shabani F. (Iran) |
|||
|
18:20 Q & A
|
|
10:45 Maternal syncope during pregnancy: Is it a real concern?
Amir Ajam Z. (Iran) |
|||
|
11:05 Chest pain during pregnancy: Is it scary as it seems?
Hosseini Z. (Iran) |
|||
|
11:25 Heart Palpitation during pregnancy: Pretty common, pretty scary.
Shahrzad S. (Iran) |
|||
|
11:45 Dyspnea during pregnancy: When to worry?
Sardari A. (Iran) |
|
12:15 Top trials in antiplatelets therapy
|
|
13:30 Case 1
Hosseini Z. (Iran) |
|||
|
13:45 Case 2
Taghipour M. (Iran) |
|||
|
14:00 Case 3
Haji-Zeinali AM. (Iran) |
|||
|
14:15 Case 4
Khalilipur E. (Iran) |
|||
|
14:30 Case 5
Alemzadeh Ansari MJ. (Iran) |
|||
|
14:45 Q & A
|
|
15:15 Case 1
Amiri A. (Iran) |
|||
|
15:30 Case 2
Hekmat HR. (Iran) |
|||
|
15:45 Case 3
Bani Fatemeh S.A. (Iran) |
|||
|
16:00 Case 4
Sajjadi M. (Iran) |
|||
|
16:15 Case 5
Heidari A. (Iran) |
|||
|
16:30 Case 6
Sobh Rakhshankhah A. (Iran) |
|
17:00 Medical or endovascular approach: imaging findings supporting
TEVAR
Rabiee P. (Iran) |
|||
|
17:20 Landmark studies in management strategy in TBAD
Sadeghipour P. (Iran) |
|||
|
17:40 Extended techniques: FEVAR, candy plug, Knickerbockers and
STABILISE concept
Moosavi J. (Iran) |
|||
|
18:00 Hybrid options in patients with TBAD
Mohebbi B. (Iran) |
|||
|
18:20 Q & A
|
|
08:30 Deep Medicine and Cardiology. Are we getting there?
Tara M. (Iran) |
|||
|
08:45 Radiomics: Invisible Findings in Cardiovascular Imaging
Fatehi M. (Iran) |
|||
|
09:00 Artificial Intelligence for Secondary Prevention of
Myocardial Infarction
Fatehi F. (Australia) |
|||
|
09:25 A Practical Guide to Use AI in Healthcare
Oveisi M. (Canada) |
|||
|
09:45 The role of AI in Cardiac Anesthesia and Perioperative Medicine
Dabbagh A. (Iran) |
|
10:00 Welcome and briefing from the president of the Iranian Heart
Association & the Congress
Noohi F. (Iran) |
|||
|
10:20 Welcome from the president of the Iranian Society of Cardiac
Surgeon & the Congress
Yousefnia MA. (Iran) |
|
10:45 CABG vs. PCI vs. OMT in CAD
Khalilipur E. (Iran) |
|
12:15 Top Trials in Revascularization
Ghasemi M. (Iran) |
|
13:30 Anthracycline-induced cardiotoxicity
Alizadehasl A. (Iran) |
|||
|
13:50 Immune checkpoint inhibitor associated cardiotoxicity
Roudini K. (Iran) |
|||
|
14:10 Indications of Cardiology consult in Cancer patient
Tavakoli S. (Iran) |
|||
|
14:30 Anti-HER2 therapy-associated cardiotoxicity
Mohseni M. (Iran) |
|||
|
14:50 Q & A
|
|
15:15 Panel Discussion
|
|||
|
16:25 Inclisiran a new potent drug for lowering LDL cholesterol
Hashemian M. (Iran) |
|
17:00 Introduction
|
|||
|
17:20 Cons
Ghanavati R. (Iran) |
|||
|
17:40 Pros
Mohamadifar A. (Iran) |
|||
|
18:00 Rebuttal (Con)
|
|||
|
18:05 Rebuttal (Pro)
|
|||
|
18:10 Final Word
|
|
07:15 How to choose a topic
|
|||
|
07:25 How to select a publisher
|
|||
|
07:35 How to arrange chapters
|
|||
|
07:45 How to collect contributors
|
|||
|
07:55 How to manage timetable
|
|||
|
08:05 How to edit the book throughout the chapters
|
|
08:30 Malfunction of oxygenator and blood leakage: a case report
Rahimi H. (Iran) |
|||
|
08:45 The Correlation of Lipid Peroxidation and Antioxidant Capacity on Perioperative Outcomes in On-Pump CABG in Adults
Gorjipour F. (Iran) |
|||
|
09:00 Simplification of Energy Equivalent Pressure formula for clinical use in pulsatile flow in on-pump cardiac
Bagherinasab M. (Iran) |
|||
|
09:15 Which Factors Influence on Mortality in Patients Undergoing Veno-Venous Extracorporeal Membrane Oxygenation (ECMO)?
Hoseinzadeh M. (Iran) |
|||
|
09:30 CRRT in cardiac surgery patients
Mortazavi SM (Iran) |
|||
|
09:50 Q & A
|
|
10:30 Cardioplegia safety and monitoring
Desuki Y. (Lebanon) |
|||
|
10:45 A Comparative Study of the Clinical Implications of Cardioplegia Infusion Between the Microplegia Technique and Del Nido Cardioplegia Among Patients Undergoing Coronary Artery Bypass Surgery
Nazari S (Iran) |
|||
|
11:00 The effect of St Thomas cold and warm blood cardioplegia on coronary sinus and arterial blood gases in patients undergoing coronary artery surgery
Hemmati N. (Iran) |
|||
|
11:15 Protective Effect of Five-cycle Arm Cuff Closure in Remote Ischemic Pre-conditioning on Myocardial Function and Clinical Outcomes in Patients Undergoing CABG
Mohammadi R. (Iran) |
|||
|
11:30 The Effects of Cold Blood Cardioplegia with and without Adenosine on Hemodynamic Status
Ghasemi F. (Iran) |
|||
|
11:45 Q & A
|
|
12:15 Top trials in Heart Failure
Kiani A. (Iran) |
|||
|
13:00 Q & A
|
|
13:30 New approach of multidisciplinary cooperation and advanced team
working
Ghanbari A. (Iran) |
|||
|
13:45 Team management of multidisciplinary groups in medical field
Al-Lawati A. (Oman) |
|||
|
14:00 Cardiology indications of ECMO
Naderi N. (Iran) |
|||
|
14:15 Successful ECMO – Right time, Right case
Daliri M. (Iran) |
|||
|
14:30 ECMO Management
Khosravi MB. (Iran) |
|||
|
14:45 Q & A
|
|
15:15 Annual General Meeting of IRANSECT & Presenting IRAN
SSECT
|
|
17:00 Echo at jeopardy
|
|
08:30 Electrophysiology EP tracing corner (Case‐based session)
Balavandi F. (Iran) Hemmati R. (Iran) Shirazi S. (Iran) Mahmoodmoradi S. (Iran) Daryanavard A. (Iran) Rezaie R. (Iran) Hadavi Bavili M. (Iran) |
|
10:30 Human sciences and nursing care
|
|
12:15 Top Trials in EP (Devices)
Hajiahmadi M. (Iran) |
|||
|
12:40 Top Trials in EP (Ablation)
Masoudkabir F. (Iran) |
|||
|
13:05 Q & A
|
|
13:30 Philosophical aspects of nursing care
|
|
15:15 Meet The Experts Post Resuscitation Care
|
|
17:00 Meet The Expert Nursing point in Cardiovascular medication administration
|
|
07:15 Frozen Elephant Truc, A to Z
Case Selection, Procedure and How to improve outcome
Mestres C. (Spain) |
|||
|
07:45 Case Presentation & Open Discussion
|
|
10:30 Echocardiography in PAH
Pourzand H. (Iran) |
|||
|
10:50 Cardiac Imaging in PAH
Pouraliakbar HR. (Iran) |
|||
|
11:10 Right Heart Catheterization
Mohammadifar A. (Iran) |
|||
|
11:30 Management, new issues in PAH
Zare E. (Iran) |
|||
|
11:50 Q & A
|
|
12:15 Comparison of American and European Guidelines for the
Management of Patients With Mitral Regurgitation
Abdi S. (Iran) |
|||
|
12:30 Patient selection in Transcatheter Mitral Valve Edge-to-Edge Repair
Using the MitraClip
Sarraf M. (USA) |
|||
|
12:45 Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip
G4 System
Sarraf M. (USA) |
|||
|
13:00 Q & A
|
|
13:30 Role of intraoperative TEE in aortic valve repair and valve sparing
operation
Salehi Omran A. (Canada) |
|||
|
13:50 Valve in Valve Procedures
Sahebjam M. (Iran) |
|||
|
14:10 Closure of paravalvular regurgitation
Shojaeifard M. (Iran) |
|||
|
14:30 MitraClip
Alizadehasl A. (Iran) |
|
15:15 When right is wrong: Surgical implications
Ahmad ZH. (Iran) |
|||
|
15:30 ECPR
Daliri M. (Iran) |
|||
|
15:45 Myocardial Protection in Heart Transplantation
Shafiei M. (Iran) |
|||
|
16:00 Mechanical Circulatory Support in AMI, Which mechanical device
for which patient
Sarraf M. (USA) |
|||
|
16:15 Discussion on Long-term results of Heart Transplant Versus VAD
|
|
17:00 Cardiac surgery Service TQM
Al-Lawati A. (Oman) |
|||
|
17:20 Cardiac surgery Curriculum in the world
Mestres C. (Spain) |
|||
|
17:40 Open Discussion
|
|
18:30 Iranian Society of Cardiac Surgeons annual General Assembly
|
|
08:30 Investigating the differences in respiratory system between
children and adults
Alirezai O. (Iran) |
|||
|
08:50 The role of physiotherapy in pulmonary rehabilitation
Abedi M. (Iran) |
|||
|
09:10 The interaction of the respiratory system with the cardiovascular System
Ravanbakhsh M. (Iran) |
|||
|
09:30 Chest X-ray in intensive care unit
Saba J. (Iran) |
|
10:30 Living with Heart Failure
Taghavi S. (Iran) |
|||
|
10:50 Exercise prescription in patients with Heart Failure
Attarbashi Moghadam B. (Iran) |
|||
|
11:10 Exercise training in patients with Heart Failure
Abolahrari Shirazi S. (Iran) |
|||
|
11:30 Design of cardiac rehabilitation registry in Hormozgan university of medical sciences
Saadat Z. (Iran) |
|||
|
11:50 The acute effects of two different intensities of resistance exercise on autonomic function in patients with heart failure – A randomized controlled trial
Saeidi Kelishadi M. (Iran) |
|
12:15 Individualized anti-platelet therapy post ACS
Alemzadeh Ansari MJ. (Iran) |
|
13:30 Cardiac Rehabilitation Workshop 1
Cardiac Rehabilitation Phase I
Cardiac Rehabilitation Phase II
Zafarnejad M. (Iran) |
|||
|
14:15 Cardiac Rehabilitation Workshop 2
Cardiac Rehabilitation Phase III
Attarbashi Moghadam B. (Iran) |
|
15:15 An introduction to CIEDs
Shahrzad S. (Iran) |
|||
|
15:45 Cardiac rehabilitation in patients with pacemaker & implantable
cardioverter defibrillator (ICD)
Saba M. (Iran) |
|||
|
16:15 Physiotherapy modalities and cardiac rhythm devices
Ghofrani M. (Iran) |
|
17:00 Pathophysiology of deep vein thrombosis
Vasaghi Gharamaleki B. (Iran) |
|||
|
17:20 Role of physical therapists in the management of individuals at risk for or diagnosed with venous thromboembolism: evidence-based clinical practice guideline
Saadat M. (Iran) |
|||
|
17:40 The association between anthropometric parameters and hs-CRP in
overweight patients with moderate hemophilia A
Parhampour B. (Iran) |
|||
|
18:00 Q & A
|
|
07:15 Infective endocarditis: An update
Boudagh S. (Iran) |
|||
|
07:30 FDG-PET/CT in infective endocarditis:
Moradnejad P. (Iran) |
|||
|
07:45 Endocarditis due to multidrug resistant bacteria:
Kamali M. (Iran) |
|||
|
07:55 Fungal endocarditis:
Manshouri S. (Iran) |
|||
|
08:05 Neurological complications of IE
Afzalnia A. (Iran) |
|
08:30 Hematopoietic stem cell transplantation at a glance
Dabiri MR. (Iran) |
|||
|
08:45 Thrombotic diseases in hematopoietic stem cell transplantation
Alizadehasl A. (Iran) |
|||
|
09:00 Arrhythmias in hematopoietic stem cell transplantation
Haghjoo M. (Iran) |
|||
|
09:15 Hematopoietic stem cell transplantation in low EF
Naderi N. (Iran) |
|||
|
09:30 Chronic GVHD in hematopoietic stem cell transplantation- cardiac
complications
Ashrafi F. (Iran) |
|
10:30 His Pacing: Does it really work?
Ghorbanisharif AR. (Iran) |
|||
|
11:00 Device detected high- rate episodes: Clinical implications and gap in
evidence
Heydari AR. (Iran) |
|||
|
11:30 Non-Responder CRT patient:What to do in daily practice
Hajimoradi B. (Iran) |
|
12:15 Quiz Hub: Manage Cases, Win Prizes! Sponsored by Arena
|
|
13:30 - Post-operative Atrial Fibrillation
- Post-operative bradyarrhythmia
- Post-operative ventricular arrhythmia
|
|
15:15 The diagnostic challenge of cardiomyopathies: when should we
suspect cardiac amyloidosis?
Nazari Z. (Iran) |
|||
|
15:35 Novel approaches in treatment of cardiac amyloidosis
Mirtajaddini M. (Iran) |
|||
|
15:55 Eosinophilic cardiomyopathy
Khoushavi M. (Iran) |
|||
|
16:15 Management of Myocarditis
Sadeghi T. (Iran) |
|
17:00 Updates in regenerative therapy for heart failure
Barekat M. (Iran) |
|||
|
17:20 Vagal nerve therapy in heart failure
Torfi E. (Iran) |
|||
|
17:40 Personalized medicine in heart failure
Hajahmadi M. (Iran) |
|||
|
18:00 The future in heart failure
Shafiei D. (Iran) |
|||
|
18:15 Q & A
|
|
18:30 Iranian Society of Heart Failure Annual General assembly
|
|
07:15 The association between DNA Polymorphisms, gene expression and
susceptibility to diseases
Taheri E. (Iran) |
|||
|
07:45 Heart disease biomarker discovery using in silico analysis and
experimental validation
Gholipour A. (Iran) |
|
10:30 General Assembly of Iranian Cardiac Nurses Society
|
|
12:15 Cardiac CT top Trials
Mojibian HR. (USA) |
|||
|
12:45 Cardiac MR top Studies
Houshmand G. (Iran) |
|
13:30 Outcomes of supracoronary repair technique in patients with
acute aortic dissection
Saeidi M. (Iran) |
|||
|
13:45 Film Session
|
|
15:15 Genes, lifestyle and cardiovascular disease
Biglari AR. (Iran) |
|||
|
15:35 Brugada Syndrome in Iran
Haghjoo M. (Iran) |
|||
|
15:50 Epigenetics and Cardiovascular Medicine
Sarrafzadegan N. (Iran) |
|||
|
16:15 Plasticity of cardiac adipose tissue in cardiovascular disease:
Molecular characterization and secretory function
Arabian M. (Iran) |
|||
|
16:30 Next Generation Sequencing in cardiovascular diseases
Kalaeinia S. (Iran) |
|
18:30 Iranian Society of Electrophysiology Annual General assembly
|
|
10:30 When should you go for PDA Stenting in PA-IVS
Malakan Rad E. (Iran) |
|||
|
10:45 PDA Stenting in PA-VSD
Ghaemi HR. (Iran) |
|||
|
11:00 RVOT Stenting in Native RVOT and Hemograft
Alizadeh B. (Iran) |
|||
|
11:15 Pulmonary Arteries Stenting post Biventricular Repair
Ghaderian M. (Iran) |
|||
|
11:30 Pulmonary artery stenting post Univentricular Approach
(Airway Concerns)
Amoozgar H. (Iran) |
|||
|
11:45 Coarctation of Aorta: Stenting by Bare Stent or Coverd Stent
When and Why?
Sayadpour K. (Iran) |
|
13:30 TOF with small PAB, Palliation or Total Correction
Vahid-shahi K. (Iran) |
|||
|
13:45 Management of RV Failure Post TFTC
Saedi S. (Iran) |
|||
|
14:00 TOF with Abnormal Coronary Arteries
Bigdelian H. (Iran) |
|||
|
14:15 Management of Free PR and Time of PVR
Samadi M. (Iran) |
|||
|
14:30 PVR , Biologic Valve or Mechanical Valve ?
Tatari H. (Iran) |
|||
|
14:45 PPVI ( Introduce of New Products )
Mortezaeian H. (Iran) |
|
15:15 New Updates and Risk Factors in Fontan Operation
Kheir-Andish Z. (Iran) |
|||
|
15:30 Fenestration; advantages and disadvantages
Hoseinzadeh M. (Iran) |
|||
|
15:45 How could you prevent Protein Loss Entropathy (PLE)
Dehghan B. (Iran) |
|||
|
16:00 Anticoagulation in Fontan
Malakan Rad E. (Iran) |
|||
|
16:15 Arrhythmia Post Fontan (Causes and management)
Sabri MR. (Iran) |
|||
|
16:30 Failing Fontan
Sabri MR. (Iran) |
|
17:00 Physical Activity,Traveling and Driving in ACHD
Aliramezani M. (Iran) |
|||
|
17:15 Premarital Counseling and Family Planning in ACHD
Keshavarz M. (Iran) |
|||
|
17:30 Pregnancy in ACHD
Ghaderian H. (Iran) |
|||
|
17:45 Non Cardiac and Cosmetic Surgery in ACHD
Mohammadi M. (Iran) |
|||
|
18:00 Coronary Artery Disease in ACHD
Ansari Z. (Iran) |
|||
|
18:15 Systemic Disease in ACHD
Pashapour P. (Iran) |
|
18:30 ISPC Meeting
Pediatric Cardiology Annual General Assembly
|
|
07:15 New recommendations for prevention of coronary heart disease
Khalili Y. (Iran) |
|||
|
07:30 How to prevent myocarditis?
Kamali M. (Iran) |
|||
|
07:45 New soft wares for education of patients with heart disease
Nikpajouh A. (Iran) |
|||
|
08:00 Prevention of congenital heart disease
Mortaz G. (Iran) |
|
10:30 Welcome Message
Noohi F. (Iran) |
|||
|
10:35 CVD Registry in Iran: A Practical Model.
Sarrafzadegan N. (Iran) |
|||
|
10:55 CVD Registry in Kuwait: A Practical Model.
Zubaid M. (Kuwait) |
|||
|
11:15 How to Use the Results of a National Registry? A Case Study from
Iran.
Khosravi AR. (Iran) |
|||
|
11:30 The Way Forward.
|
|
13:30 Obesity as a chronic disease.
Ghaemmaghami Z. (Iran) |
|||
|
13:40 Nutrition therapy in obesity (focus on obese patients with heart
failure)
Hashemi B. (Iran) |
|||
|
14:10 Drug therapy in obesity.
Ghaemmaghami Z. (Iran) |
|||
|
14:35 Bariatric surgery in heart failure.
Mousavizadeh M. (Iran) |
|
15:15 Sleep Apnea in cardiac surgery patients
Zandi T. (Iran) |
|||
|
15:30 Brain Protection in cardiac surgery patients
Bilehjani I. (Iran) |
|||
|
15:45 Renal failure in cardiac surgery
Bakhshaei MH. (Iran) |
|||
|
16:00 Pain Management in Addict Patients
Jarineshin.H. (Iran) |
|||
|
16:15 COVID-19 and Cardiac Anesthesia
Manshouri S. (Iran) |
|||
|
16:30 Myocardial protection during cardiopulmonary bypass
Zamani A. (Iran) |
|
17:00 Advanced Hemodynamic Monitoring in Cardiac Anesthesia
Jalali AR. (Iran) |
|||
|
17:15 Neurophysiologic Monitoring in Cardiac Surgery
Nooralishahi B. (Iran) |
|||
|
17:30 Cardiac Output Monitoring in Cardiac Surgery using IO-TEE
Kiani A. (Iran) |
|||
|
17:45 Noninvasive Cardiac Output Monitoring During Cardiac Anesthesia
Sheybani S. (Iran) |
|||
|
18:00 Monitoring in Cardiac surgery
Mansouri M. (Iran) |
|||
|
18:15 Mixed Venous Monitoring during cardiac Anesthesia
Asgari H. (Iran) |
|
18:30 Iranian Society of Cardiac Anesthesiologist Annual Assembly
|
|
10:30 CMR findings of HCM
Alizadeh Sani Z. (Iran) |
|||
|
10:50 CMR findings of Amyloidosis
Houshmand G. (Iran) |
|||
|
11:10 CMR findings of Sarcoidosis
Omidi S. (Iran) |
|||
|
11:30 CMR findings of Myocarditis
Kasaei SM. (Iran) |
|||
|
11:50 Q & A
|
|
12:15 Why I Use The Perceval
|
|||
|
12:30 SU AVR versus TAVI
Ghavidel AA. (Iran) |
|||
|
12:45 Perceval in Complex Cardiac Surgery Procedures
Hosseini S. (Iran) |
|||
|
13:00 Open discussion
|
|
13:30 Case 1
Hashemi Fard O. (Iran) |
|||
|
13:45 Case 2
Ahmadieh A. (Iran) |
|||
|
14:00 Case 3
Ghofraniha A. (Iran) |
|||
|
14:15 Case 4
Norouzi J. (Iran) |
|||
|
14:30 Case 5
Sadeghi H. (Iran) |
|||
|
14:45 Case 6
Vosoughi S. (Iran) |
|
15:15 IVUS
Mehrpouya M. (Iran) |
|||
|
15:30 FFR
Bagheri B. (Iran) |
|||
|
15:45 MSCT in guided PCI
Pouraliakbar HR. (Iran) |
|||
|
16:00 NIFFR
Ghasemi M. (Iran) |
|||
|
16:15 OCT
Alemzadeh Ansari MJ. (Iran) |
|||
|
16:30 Q & A
|
|
17:00 Case 1
Zibaeenejad MJ. (Iran) |
|||
|
17:15 Case 2
Rai A. (Iran) Saeedi M.R. (Iran) |
|||
|
17:30 Case 3
Tolouei M. (Iran) |
|||
|
17:45 Case 4
Mohammadi Lord A. (Iran) |
|||
|
18:00 Case 5
Esmaeeli M. (Iran) |
|||
|
18:15 Case 6
Hashemi A. (Iran) |
|
07:15 Presenter
Khalilipur E. (Iran) |
|||
|
08:00 Panel Discussion
|
|
08:30 Panel Discussion
|
|||
|
09:45 Transcatheter treatment for tricuspid valve diseases
Oto A. (Turkey) |
|
10:30 Aortic Stenosis
Hosseini Z. (Iran) |
|
12:15 An overview of Firehawk, a novel target eluting coronary stent
Elahifar A. (Iran) |
|
13:30 Are we still in a pandemic?
Tabarsi P. (Iran) |
|||
|
13:50 COVID-19 and acute myocardial injury
Sattarzadeh R. (Iran) |
|||
|
14:10 Long COVID syndrome
Tavana S. (Iran) |
|||
|
14:30 Thrombotic Complications of COVID-19
Bikdeli B. (USA) |
|||
|
14:50 Q & A
|
|
17:00 ECG in AF patients, differential diagnosis, drug side effects and more.
Fazelifar AF. (Iran) |
|||
|
17:20 Medical treatment in AF patients, drug selection, anti coagulation and
more
Sattar F. (Iran) |
|||
|
17:40 Invasive treatment in AF patients: RF, Cryoballoon, AVN ablation and
more.
Zandi Z. (Iran) |
|||
|
18:00 Risk factor management in AF: Obesity, Sleep apnea, Hypertension
and more
Hajiabady M. (Iran) |
|||
|
18:20 Q & A
|
|
08:30 Importance of online blood gas monitor during CPB
Desuki Y. (Lebanon) |
|||
|
08:45 Perfusionist and accidents
Shafiei.H (Iran) Moradi AR. (Iran) |
|
08:30 ECMO
Roshan Y. (Iran) Fatahi M. (Iran) |
|||
|
09:45 Brief of Cell Salvage System
Desuki Y. (Lebanon) |
|
10:30 The effect of infusion of Dexmedetomidine to aortic root before aortic
cross-clamp removal on the myocardial protection in patients
undergoing Mitral Valve Replacement/repair
Hajipour A (Iran) |
|||
|
10:45 The Effect of Pulsatile Perfusion on Liver Function and Clinical
Outcome in Pediatric Patients Undergoing Congenital Heart Surgery
Nadi P. (Iran) |
|||
|
11:00 Target flow achievement on A comparative rapid and delayed full- -
brain tissue oxygen index and ischemic events
Bagherinasab M. (Iran) |
|||
|
11:15 Remote ischemic preconditioning effects on inflammatory markers
and myocardial protection in coronary artery bypass graft surgery
Gorjipour F. (Iran) |
|||
|
11:30 The effect of Del Nido versus custodiol cardioplegia on clinical
outcomes and troponin-I changes among pediatrics with tetralogy of
Fallot undergoing cardiopulmonary bypass
Heidarinia S. (Iran) |
|||
|
11:45 Q & A
|
|
10:30 The role of cardiac rehabilitation in recovery, health and return to a normal life
Zafarnejad M. (Iran) |
|||
|
10:50 Mental health and its importance in rehabilitation of cardiac patients
Ganji T. (Iran) |
|||
|
11:10 Maintaining heart health, prevention or rehabilitation?
Nikpour S. (Iran) |
|||
|
11:30 Nutritional recommendations for cardiac patients
Aghasi M. (Iran) |
|
07:15 Endocarditis Management
Mestres C. (Spain) |
|
08:30 Fetal Cardiomyopathy
Tabib A. (Iran) |
|||
|
08:45 Fetal complications of maternal SLE
Aghaiee-Moghaddam E. (Iran) |
|||
|
09:00 Fetal Cardiac Tumors
Rashidi-Ghader F. (Iran) |
|||
|
09:15 Fetal Echo (Complex Case Presentation)
Follow up or Abortion?
Management of AVB in Fetus.
Zamani H. (Iran) Rajabi R. (Iran) Golbabaie AR. (Iran) |
|
10:30 Tubular PDA Closure: A Contravercial issue
Edraki MR. (Iran) |
|||
|
10:40 Challenging in post MI VSR Closure by Device
Molaie A. (Iran) |
|||
|
11:00 Coronary Thrombosis in Kawasaki Disease
Mahdavi CH. (Iran) |
|||
|
11:10 Secondary MR in CHD with Left to Right Shunt
Zamani H. (Iran) |
|||
|
11:20 WPW and Peripartum Cardiomyopathy
Dehghan B. (Iran) |
|||
|
11:30 Heart MM in Neonate: Be Careful
Sheykhian T. (Iran) |
|||
|
11:40 External Iliac Thrombosis post COA Stenting
Ghaemi HR. (Iran) |
|||
|
11:50 Q & A
|
|
07:15 Impact of subanesthetic Ketamine on awakening and postanesthetic
depression and anxiety
Ferasatkish.R (Iran) Hendinejhad.A (Iran) |
|||
|
07:25 Compairing effect of sedation with dexmedtomidine and propofol on
Sleep quality of patients after cardiac surgery
Azarfarin R. (Iran) Ghadimi M. (Iran) |
|||
|
07:35 Comparison of the Nasopharynx and Forehead Skin Temperature
Monitoring During Cardiac Surgery under Cardiopulmonary Bypass
Mahoori AR. (Iran) Hassani E. (Iran) Khanahmadi Sh. (Iran) |
|||
|
07:45 The effect of Mechanical cough-assist device on respiratory and
hemodynamic parameters in patients of cardiac surgery.
Tahereh Abolghasemi (Iran) Ziyaeifard M. (Iran) Sadeghi H. (Iran) Akbar Ghamari (Iran) |
|||
|
07:55 The relationship between the perioperative white blood cell count and
atrial fibrillation, in open heart surgery
Nilofar Zadehseraji (Iran) Mohsen Ziyaeifard (Iran) Nahid Aghdaii (Iran) Movaseghi Gh. (Iran) Behrooz Zaman (Iran) |
|||
|
08:05 Risk factors and success of cardiopulmonary resuscitation after cardiac
surgery
Parisa Ziyaeifard (Iran) Mohsen Ziyaeifard (Iran) Rasoul Azarfarin (Iran) Touraj Babaei (Iran) |
|
08:30 Quality of Life after CABG, Case Presentation
Fatemeh Farmani (Iran) Mashallah Naghilou (Iran) |
|||
|
09:00 Benefits of balance training in adult after cardiac surgery
Fasihnia H. (Iran) |
|||
|
09:20 Prevalence of musculoskeletal disorder after coronary artery bypass graft: A review article
Jafari M.S. (Iran) |
|||
|
09:40 Exercise prescription for improving cardiorespiratory fitness in healthy older adults
|
|
08:30 Facility based patient and program monitoring approach for
reducing burden of CVD and hypertention
Farzadfar F. (WHO) |
|||
|
08:45 Causality in cardiovascular research
Motevalian A. (Iran) |
|||
|
09:00 Bioprinting application in cardiovascular medicine: achievements
and challenges
Abolfathi N. (Iran) |
|||
|
09:15 Research from scientometric to impact
Akhunzadeh S. (Iran) |
|||
|
09:30 Iranian Registry of Atrial Fibrillation: Second national report
Haghjoo M. (Iran) |
|||
|
09:35 Impact of opium consumption on mid-term outcomes of surgical
revascularization: should we be afraid of quitting?
Masoudkabir F. (Iran) |
|||
|
09:40 INSPIRATION Trial
Sadeghipour P. (Iran) |
|||
|
09:45 Isfahan Healthy Heart Program (IHHP): A successful model for the
prevention and control of Cardiovascular Diseases in low and
middle income countries.
Sarrafzadegan N. (Iran) |
|
10:30 New Horizon in endovascular treatment of aortic diseases
Haulon S. (France) |
|||
|
10:45 Pulse Field Ablation
Emkanjoo Z. (Iran) |
|||
|
11:00 Valve Replacement in Era of TAVI
Jahangiri M. (Iran) |
|||
|
11:20 New Horizon in the management of peripheral vascular diseases
Shishehbor M. (USA) |
|||
|
11:30 Flozinate across the spectrum
Amin A. (Iran) |
|||
|
11:45 Q&A
|
